L Patrick Gage - Net Worth and Insider Trading
L Patrick Gage Net Worth
The estimated net worth of L Patrick Gage is at least $2 Million dollars as of 2024-05-11. L Patrick Gage is the Director of Cytokinetics Inc and owns about 30,782 shares of Cytokinetics Inc (CYTK) stock worth over $2 Million. L Patrick Gage is the Director of PDL BioPharma Inc and owns about 7,555 shares of PDL BioPharma Inc (PDLI) stock worth over $18,661. L Patrick Gage is also the Director of Tetraphase Pharmaceuticals Inc and owns about 1,944 shares of Tetraphase Pharmaceuticals Inc (TTPH) stock worth over $4,277. Details can be seen in L Patrick Gage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that L Patrick Gage has not made any transactions after 2021-11-08 and currently still holds the listed stock(s).
Transaction Summary of L Patrick Gage
L Patrick Gage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L Patrick Gage owns 3 companies in total, including Tetraphase Pharmaceuticals Inc (TTPH) , Cytokinetics Inc (CYTK) , and PDL BioPharma Inc (PDLI) .
Click here to see the complete history of L Patrick Gage’s form 4 insider trades.
Insider Ownership Summary of L Patrick Gage
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTPH | Tetraphase Pharmaceuticals Inc | 2020-07-28 | director |
| CYTK | Cytokinetics Inc | 2021-11-08 | director |
| PDLI | PDL BioPharma Inc | 2008-04-28 | director & Interim CEO |
L Patrick Gage Latest Holdings Summary
L Patrick Gage currently owns a total of 3 stocks. Among these stocks, L Patrick Gage owns 30,782 shares of Cytokinetics Inc (CYTK) as of November 8, 2021, with a value of $2 Million and a weighting of 98.81%. L Patrick Gage owns 7,555 shares of PDL BioPharma Inc (PDLI) as of May 5, 2005, with a value of $18,661 and a weighting of 0.96%. L Patrick Gage also owns 1,944 shares of Tetraphase Pharmaceuticals Inc (TTPH) as of November 29, 2017, with a value of $4,277 and a weighting of 0.22%.
Latest Holdings of L Patrick Gage
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2021-11-08 | 30,782 | 62.10 | 1,911,562 |
| PDLI | PDL BioPharma Inc | 2005-05-05 | 7,555 | 2.47 | 18,661 |
| TTPH | Tetraphase Pharmaceuticals Inc | 2017-11-29 | 1,944 | 2.20 | 4,277 |
Holding Weightings of L Patrick Gage
L Patrick Gage Form 4 Trading Tracker
According to the SEC Form 4 filings, L Patrick Gage has made a total of 5 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Cytokinetics Inc is the sale of 26,468 shares on November 8, 2021, which brought L Patrick Gage around $1 Million.
According to the SEC Form 4 filings, L Patrick Gage has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 5,555 shares on May 5, 2005, which cost L Patrick Gage around $100,268.
According to the SEC Form 4 filings, L Patrick Gage has made a total of 0 transactions in Tetraphase Pharmaceuticals Inc (TTPH) over the past 5 years. The most-recent trade in Tetraphase Pharmaceuticals Inc is the acquisition of 194 shares on November 29, 2017, which cost L Patrick Gage around $25,026.
Insider Trading History of L Patrick Gage
- 1
L Patrick Gage Trading Performance
GuruFocus tracks the stock performance after each of L Patrick Gage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by L Patrick Gage is 22.58%. GuruFocus also compares L Patrick Gage's trading performance to market benchmark return within the same time period. The performance of stocks bought by L Patrick Gage within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how L Patrick Gage's insider trading performs compared to the benchmark.
Performance of L Patrick Gage
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.23 | | | | | |
| Relative Return to S&P 500(%) | 6.25 | | | | | |
L Patrick Gage Ownership Network
L Patrick Gage Owned Company Details
What does Tetraphase Pharmaceuticals Inc do?
Who are the key executives at Tetraphase Pharmaceuticals Inc?
L Patrick Gage is the director of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Steven Boyd , and director & 10 percent owner Armistice Capital Master Fund Ltd. .
Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tetraphase Pharmaceuticals Inc Insider Transactions
L Patrick Gage Mailing Address
Above is the net worth, insider trading, and ownership report for L Patrick Gage. You might contact L Patrick Gage via mailing address: C/o Neose Technologies, 102 Witmer Rd, Horsham Pa 19044.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
